Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells

Cellular Physiology and Biochemistry

Volumn 32, Issue 1, 2013, Pages 100-110

  Xue, Jing ^a,b,c   Wang, Shuai ^c   Wu, Jinchang ^a,b   Hannafon, Bethany N ^c   Ding, Wei Qun ^c,d  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

A2780; Cancer; Heme oxygenase 1; MDA MB 231; Nrf2; Zinc

Indexed keywords

CHELATING AGENT; CLIOQUINOL; HEME OXYGENASE 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; ZINC; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ZINC CHLORIDE;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; BREAST CANCER CELL LINE; CYTOPLASM; GENE EXPRESSION; GENE SILENCING; LUCIFERASE ASSAY; OVARIAN CANCER CELL LINE; OXIDATIVE STRESS; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL LINE, TUMOR; CLIOQUINOL; ETHYLENEDIAMINES; HEME OXYGENASE-1; HUMANS; NF-E2-RELATED FACTOR 2; PPAR ALPHA; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; ZINC;

EID: 84880184206     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000350128     Document Type: Article

References (35)

1. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, Dulak J: Heme oxygenase-1 and the vascular bed: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2008;10:1767-1812.
2. Fang J, Nakamura H, Iyer AK: Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 2007;15:475-486.
3. Nuhn P, Kunzli BM, Hennig R, Mitkus T, Ramanauskas T, Nobiling R, Meuer SC, Friess H, Berberat PO: Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer 2009;8:37.
4. Gleixner KV, Mayerhofer M, Vales A, Gruze A, Hormann G, Cerny-Reiterer S, Lackner E, Hadzijusufovic E, Herrmann H, Iyer AK, Krauth MT, Pickl WF, Marian B, Panzer-Grumayer R, Sillaber C, Maeda H, Zielinski C, Valent P: Targeting of hsp32 in solid tumors and leukemias: A novel approach to optimize anticancer therapy. Curr Cancer Drug Targets 2009;9:675-689.
5. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME: Zinc and human health: An update. Arch Toxicol 2012;86:521-534.
6. Alam S, Kelleher SL: Cellular mechanisms of zinc dysregulation: A perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutrients 2012;4:875-903.
7. Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LY: Dysregulation of mir-31 and mir-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012;33:1736-1744.
8. Costello LC, Franklin RB: Zinc is decreased in prostate cancer: An established relationship of prostate cancer! J Biol Inorg Chem 2011;16:3-8.
9. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE: Anticancer activity of the antibiotic clioquinol. Cancer Res 2005;65:3389-3395.
10. Ding WQ, Lind SE: Metal ionophores - an emerging class of anticancer drugs. IUBMB Life 2009;61:1013-1018.
11. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP: Clioquinol, a therapeutic agent for alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-in-ducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res 2007;67:1636-1644.
12. Yu H, Zhou Y, Lind SE, Ding WQ: Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 2009;417:133-139.
13. Zheng J, Zhang XX, Yu H, Taggart JE, Ding WQ: Zinc at cytotoxic concentrations affects posttranscriptional events of gene expression in cancer cells. Cell Physiol Biochem 2012;29:181-188.
14. Zhang X, Yu H, Lou JR, Zheng J, Zhu H, Popescu NI, Lupu F, Lind SE, Ding WQ: Microrna-19 (mir-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 2011;286:1429-1435.
15. Zhou J, Zhang S, Xue J, Avery J, Wu J, Lind SE, Ding WQ: Activation of peroxisome proliferator-activated receptor alpha (pparalpha) suppresses hypoxia-inducible factor-1alpha (hif-1alpha) signaling in cancer cells. J Biol Chem 2012;287:35161-35169.
16. Rushworth SA, Chen XL, Mackman N, Ogborne RM, O'Connell MA: Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via nrf2 and protein kinase c. J Immunol 2005;175:4408-4415.
17. Rushworth SA, MacEwan DJ: Ho-1 underlies resistance of aml cells to tnf-induced apoptosis. Blood 2008;111:3793-3801.
18. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, Leitinger N: Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2007;27:1276-1282.
19. Tuller ER, Beavers CT, Lou JR, Ihnat MA, Benbrook DM, Ding WQ: Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: The involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol 2009;76:588-595.
20. Ding WQ, Yu HJ, Lind SE: Zinc-binding compounds induce cancer cell death via distinct modes of action. Cancer Lett 2008;271:251-259.
21. Jiang H, Taggart JE, Zhang X, Benbrook DM, Lind SE, Ding WQ: Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline). Cancer Lett 2011;312:11-17.
22. Wang S, Avery JE, Hannafon BN, Lind SE, Ding WQ: Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: The involvement of the wnt/beta-catenin signaling pathway. Biochem Pharmacol 2013;85:1611-1618.
23. 2+ -in-duced cortical neuronal death. Neuropharmacology 2003;45:420-428.
24. Medici V, Sturniolo GC: Tetrathiomolybdate, a copper chelator for the treatment of wilson disease, pulmonary fibrosis and other indications. IDrugs 2008;11:592-606.
25. Wiseman DA, Sharma S, Black SM: Elevated zinc induces endothelial apoptosis via disruption of glutathione metabolism: Role of the adp translocator. Biometals 2010;23:19-30.
26. Zheng J, Lou JR, Zhang XX, Benbrook DM, Hanigan MH, Lind SE, Ding WQ: N-acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death. Cancer Lett 2010;298:186-194.
27. Srisook K, Kim C, Cha YN: Molecular mechanisms involved in enhancing ho-1 expression: De-repression by heme and activation by nrf2, the "one-two" punch. Antioxid Redox Signal 2005;7:1674-1687.
28. Wright MM, Kim J, Hock TD, Leitinger N, Freeman BA, Agarwal A: Human haem oxygenase-1 induction by nitro-linoleic acid is mediated by camp, ap-1 and e-box response element interactions. Biochem J 2009;422:353-361.
29. Durante W, Peyton KJ, Schafer AI: Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19:2666-2672.
30. Liang M, Croatt AJ, Nath KA: Mechanisms underlying induction of heme oxygenase-1 by nitric oxide in renal tubular epithelial cells. Am J Physiol Renal Physiol 2000;279:F728-735.
31. Rothfuss A, Radermacher P, Speit G: Involvement of heme oxygenase-1 (ho-1) in the adaptive protection of human lymphocytes after hyperbaric oxygen (hbo) treatment. Carcinogenesis 2001;22:1979-1985.
32. Margalit O, Simon AJ, Yakubov E, Puca R, Yosepovich A, Avivi C, Jacob-Hirsch J, Gelernter I, Harmelin A, Barshack I, Rechavi G, D'Orazi G, Givol D, Amariglio N: Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. Int J Cancer 2012;131:E562-568.
33. Nardinocchi L, Pantisano V, Puca R, Porru M, Aiello A, Grasselli A, Leonetti C, Safran M, Rechavi G, Givol D, Farsetti A, D'Orazi G: Zinc downregulates hif-1alpha and inhibits its activity in tumor cells in vitro and in vivo. PloS one 2010;5:e15048.
34. O'Halloran TV: Transition metals in control of gene expression. Science 1993;261:715-725.
35. Tuller ER, Brock AL, Yu H, Lou JR, Benbrook DM, Ding WQ: Pparalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 2009;77:1480-1486.